Intelligence · Clinical Development
Pipeline search results
Programs matching “breast-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 272 pipeline programs matching "breast-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dendritic Cell Vaccination
Quantum Biopharma
Breast Cancer
1 trial -
Dendritic Cell/Tumor Fusion Vaccine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Doxorubicin liposome
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dragon Boat Training
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
ENMD-2076
CASI Pharmaceuticals
Triple Negative Breast Cancer
1 trial -
Elacestrant
Context Therapeutics
Breast Cancer
2 trials -
Entinostat
Syndax Pharmaceuticals
ER+ Breast Cancer
1 trial -
Entinostat
KYOWA KIRIN AUSTRALIA PTY LTD
Advanced or Recurrent Breast Cancer
1 trial -
Entrectinib
Hoffmann-La Roche
Breast Cancer
1 trial -
Enzalutamide
CORCEPT THERAPEUTICS INC
Metastatic Breast Cancer
1 trial -
Eribulin mesylate
HALOZYME THERAPEUTICS, INC.
Metastatic Breast Cancer
1 trial -
Evorpacept (ALX148)
ALX ONCOLOGY HOLDINGS INC
Breast Cancer, Metastatic
1 trial -
Exercise Training
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
FWD1802
Forward Pharmaceuticals Co.,
Metastatic Breast Cancer
1 trial -
Fulvestrant
Syndax Pharmaceuticals
Breast Cancer
1 trial -
Fulvestrant
United Therapeutics Europe Ltd
Advanced Breast Cancer
1 trial -
Fulvestrant with Enzalutamide
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Functional Precision Oncology
United Therapeutics Europe Ltd
Breast Cancer Recurrent
1 trial -
Giredestrant
Hoffmann-La Roche
Early Breast Cancer
1 trial -
HKI-272
PUMA BIOTECHNOLOGY, INC.
Advanced Breast Cancer
2 trials -
HKI-272
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
Herzuma
Vera Therapeutics
HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study
1 trial -
Hydrogen Peroxide
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
IDE574
IDEAYA Biosciences
ER+, HER 2- Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.